BEAMBeam Therapeutics Inc.

$3B

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6,000

Gross Profit

-$13M-208950.0% margin

Operating Income

-$18M-300400.0% margin

Net Income

-$19M-316750.0% margin

EPS (Diluted)

$-0.54

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$18M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$171M

Total Liabilities

$44M

Stockholders' Equity

$127M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6,000	$0	—
Gross Profit	-$13M	-$6M	-100.5%
Operating Income	-$18M	-$13M	-42.1%
Net Income	-$19M	-$70M	+72.8%

BEAM Q3 2019 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena